During the late-breaking research session at the 2026 AAD Annual Meeting 2026, Mary Spellman, MD, shared successful news about intratumoral PH762 for cutaneous carcinomas.
Mary C. Spellman, MD
Advertisement
Dr Spellman is a dermatologist and a clinical researcher in drug development.
Articles by Mary C. Spellman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Real-World Study Finds Experienced Dermatologists Outperform AI in Skin Cancer Diagnosis
2
New Consensus Defines Remission, Disease Activity in Atopic Dermatitis
3
Beyond Retinol: Evaluating the Stability, Safety, and Gene-Expression Profile of Bakuchiol Ferulate
4
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
5